BlumensteinJ.J.CopelandT.D.OroszlanS., and MichejdaC.J. (1989) Synthetic non-peptide inhibitors of HIV protease. Biochem Biophys Res Commun163: 980–987.
2.
CooperJ.B.FoundlingS.I.BlundellT.L.BogerJ.JuppR.A., and KayJ. (1989) X-ray studies of aspartic proteinase — statine inhibitor complexes. Biochemistry28: 8596–8603.
3.
JuppR.A.DunnB.M.JacobsJ.W.VlasukG.ArcuriK.E.VeberD.F.PerlowD.S.PayneL.S.BogerJ.de LaszloS.ChakravartyP.K.tenBroekeJ.HangauerD.G.OndeykaD.GreenleeW.J., and KayJ. (1990) The selectivity of statine-based inhibitors against various human aspartic proteinases. Biochem J265: 871–878.
4.
KayJ., and DunnB.M. (1990) Viral proteinases: weakness in strength. Biochim Biophys Acta1048: 1–18.
5.
KrausslichH.G.IngrahamR.H.SkoogM.T.WimmerE.PallaiP.V., and CarterC.A. (1989) Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides. Proc Natl Acad Sci USA86: 807–811.
6.
LapattoR.BlundellT.L.HemmingsA.OveringtonJ.WilderspinA.WoodS.MersonJ.R.WhittleP.J.DanleyD.F.GeogheganK.F.HawrylikS.J.LeeS.E.ScheldK.G., and HobartP.M. (1989) X-ray analysis of HIV-1 proteinase at 2.7 Å resolution confirms structural homology among retroviral enzymes. Nature342: 299–302.
7.
LouisJ.M.SmithC.A.D.WondrakE.M.MoraP.T., and OroszlanS. (1989) Substitution mutations of the highly conserved arginine 87 of HIV-1 protease result in loss of proteolytic activity. Biochem Biophys Res Commun164: 30–38.
8.
MillerM.SathyanarayanaB.K.WlodawerA.TothM.V.MarshallG.R.ClawsonL.SelkL.SchneiderJ., and KentS.B.H. (1989a) Structure of complex of synthetic HIV-1 protease with a substrate-based inhibitor at 2–3 Å resolution. Science246: 1149–1152.
9.
MillerM.JaskolskiM.RaoJ.K.M.LeisJ., and WlodawerA. (1989b) Crystal structure of a retroviral protease proves relationship to aspartic protease family. Nature337: 576–579.
10.
MooreM.L.BryanW.M.FakhouryS.A.MagaardV.W.HuffmanW.F.DaytonB.D.MeekT.D.HylandL.DreyerG.B.MetcalfB.W.StricklerJ.E.GorniakJ.G., and DebouckC. (1989) Peptide substrates and inhibitors of the HIV-1 protease. Biochem Biophys Res Commun159: 420–425.
11.
PalR.GalloR.C., and SarnagadharanM.G. (1988) Processing of the structural proteins of human immunodeficiency virus type 1 in the presence of monensin and cerulenin. Proc Natl Acad Sci USA85: 9283–9286.
12.
PearlL.H., and TaylorW.R. (1987) A structural model for the retroviral proteases. Nature329: 351–354.
13.
RichardsA.D.RobertsR.F.DunnB.M.GravesM.C., and KayJ. (1989a) FEBS Letts247: 113–117.
14.
RichardsA.D.BroadhurstA.RitchieA.J.DunnB.M., and KayJ. (1989b) Inhibition of the aspartic proteinase from HIV-2. FEBS Letts253: 214–216.
15.
RichardsA.D.PhylipL.H.FarmerieW.G.ScarboroughP.E.AlvarezA.DunnB.M.HirelPh.-H.KonvalinkaJ.StropP.PavlickovaL.KostkaV., and KayJ. (1990) Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem, in press.
16.
SchechterI., and BergerA. (1967) On the size of the active site in proteases. I. Papain. Biochem Biophys Res Commun27: 157–162.
17.
WeberI.T.MillerM.JaskolskiM.LeisJ.SkalkaA.M., and WlodawerA. (1989) Molecular modelling of the HIV-1 protease and its substrate binding site. Science243: 928–931.
18.
WlodawerA.MillerM.JaskolskiM.SathyanarayanaB.K.BaldwinE.WeberI.T.SelkL.M.ClawsonL.SchneiderJ., and KentS.B.H. (1989) Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease. Science245: 616–621.